Patent · US Active

Use of glycolipids as adjuvants

US8211463B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

Helmholtz-Zentrum Für Infektionsforschung GmbH · DE

Inventors

Thomas Ebensen · Hannover, DE
Michael Morr · Wolfenbüttel, DE
Carlos Guzman · Wolfenbüttel, DE
Goetz Milkereit · Hamburg, DE

Key dates

Filing date	Sep 6, 2007
Grant date	Jul 3, 2012
Priority date	—
Expiry date	Jun 8, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/55511
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to adjuvants of the glycolipid type and their uses in pharmaceutical compositions, like in vaccines. In particular, the present invention provides new uses of compounds useful as adjuvants for prophylactic and/or therapeutic vaccination in the treatment of infectious diseases, inflammatory diseases, autoimmune diseases, tumors and allergies. The compounds are particularly useful not only as systemic, but preferably as mucosal adjuvants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.